Hussain Y, Cui JH, Khan H, Aschner M, Batiha GES, Jeandet P. Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition. Med Oncol. 2021;38(6):66.
Article CAS PubMed Google Scholar
Ganai SA, Sheikh FA, Baba ZA, Mir MA, Mantoo MA, Yatoo MA. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated. Phytother Res. 2021;35(7):3509–32.
Article CAS PubMed Google Scholar
Ahmed S, Khan H, Fratantonio D, Hasan MM, Sharifi S, Fathi N, et al. Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives. Phytomedicine. 2019;59:152883.
Article CAS PubMed Google Scholar
Fasoulakis Z, Koutras A, Syllaios A, Schizas D, Garmpis N, Diakosavvas M, et al. Breast Cancer Apoptosis Therapeutic Role Luteolin chr. 2021;116(2):170.
Ambasta RK, Gupta R, Kumar D, Bhattacharya S, Sarkar A, Kumar P. Can luteolin be a therapeutic molecule for both colon cancer and diabetes? Brief Funct Genomics. 2019;18(4):230–9.
Pan J, Cai X, Zheng X, Zhu X, Feng J, Wang X. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways. Tissue Cell. 2022;75:101740.
Article CAS PubMed Google Scholar
Ye Y, Huang Z, Chen M, Mo Y, Mo Z. Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets. Front Endocrinol. 2022;12:802447.
Tuorkey MJ. Molecular targets of luteolin in cancer. Eur J Cancer Prev. 2016;25(1):65–76.
Article CAS PubMed PubMed Central Google Scholar
Imran M, Rauf A, Abu-Izneid T, Nadeem M, Shariati MA, Khan IA, et al. Luteolin, a flavonoid, as an anticancer agent: A review. Biomed Pharmacother. 2019;112:108612.
Article CAS PubMed Google Scholar
Lin Y, Shi R, Wang X, Shen HM. Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy. CCDT. 2008;8(7):634–46.
Rauf A, Wilairatana P, Joshi PB, Ahmad Z, Olatunde A, Hafeez N, et al. Revisiting luteolin: An updated review on its anticancer potential. Heliyon. 2024;10(5):e26701.
Article CAS PubMed PubMed Central Google Scholar
Karmarkar S, Garber R, Genchanok Y, George S, Yang X, Hammond R. Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. J Chromatogr Sci. 2011;49(6):439–46.
Article CAS PubMed Google Scholar
Harish V, Almalki WH, Alshehri A, Alzahrani A, Gupta MM, Alzarea SI, et al. Quality by Design (QbD) Based Method for Estimation of Xanthohumol in Bulk and Solid Lipid Nanoparticles and Validation. Molecules. 2023;28(2):472.
Article CAS PubMed PubMed Central Google Scholar
Azhakesan A, Kuppusamy S. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability Studies. ACS Omega. 2023;8(8):7407–14.
Article CAS PubMed PubMed Central Google Scholar
Lasić K, Mornar A, Nigović B. Quality by Design (QbD) approach for the development of a rapid UHPLC method for simultaneous determination of aglycone and glycoside forms of isoflavones in dietary supplements. Anal Methods. 2020;12(16):2082–92.
Zhang Q, Li J, Wang C, Sun W, Zhang Z, Cheng W. A gradient HPLC method for the quality control of chlorogenic acid, linarin and luteolin in Flos Chrysanthemi Indici suppository. J Pharm Biomed Anal. 2007;43(2):753–7.
Jansen A, Schaffka VM, Egg CMS, Camargo GDA, Farago PV. Development and Validation of an RP-HPLC/DAD Method for Luteolin Quantification in Novel Hydroxyapatite Nanocomposites. Braz arch biol technol. 2025;68:e25241041.
Che Zain MS, Osman MF, Lee SY, Shaari K. UHPLC-UV/PDA Method Validation for Simultaneous Quantification of Luteolin and Apigenin Derivatives from Elaeis guineensis Leaf Extracts: An Application for Antioxidant Herbal Preparation. Molecules. 2021;26(4):1084.
Comments (0)